The density of MHC II+CD11c+ cells and CD8+ T cells in the circulation of tumour-bearing mice treated with the combination of the hydrogel microsphere vaccine and IRE was significantly higher than that in mice treated with IRE monotherapy (Fig. 6e–g). The gene discussed is CD8A; the disease is neoplasm.